BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

H&S reform back with a vengeance
Law & Regulation

Bronwyn Heenan: H&S reform back with a vengeance

With all these changes, let's watch this space and wait for the details.

Bronwyn Heenan 04 Apr 2025
Fixing the public service
Opinion

Deb Te Kawa: Fixing the public service

Public Sector Act reform rightly aims at results, rather than cuts.

Deb Te Kawa 03 Apr 2025
Off-the-shelf AI leading the way
Opinion

Peter Griffin: Off-the-shelf AI leading the way

Long-promised productivity gains from AI will soon be reflected in NZ's economy.

Peter Griffin 02 Apr 2025